Advertisement

Topics

Kisqali receives FDA Breakthrough Therapy for advanced breast cancer

06:01 EST 3 Jan 2018 | European Pharmaceutical Review

KisqaliKisqali receives FDA Breakthrough Therapy designation for initial endocrine-based treatment of pre- or perimenopausal women with HR+/HER2- advanced or metastatic breast cancer...

Original Article: Kisqali receives FDA Breakthrough Therapy for advanced breast cancer

NEXT ARTICLE

More From BioPortfolio on "Kisqali receives FDA Breakthrough Therapy for advanced breast cancer"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...